| CASE REPORT |
|
| Year : 2022 | Volume
: 13
| Issue : 2 | Page : 212-220 |
|
|
Alternative approach to treatment of unusual site giant cell tumor at cervical spine: A case report and review of literature
Seyed Reza Mousavi1, Alireza Rezvani2, Keyvan Eghbal3, Mohammadhadi Amir Shahpari Motlagh3, Amir Reza Dehghanian4, Sanaz Taherpour3, Majidreza Farrokhi1
1 Department of Neurosurgery; Shiraz Neuroscience Research Center, Shiraz University of Medical Science, Shiraz, Iran
2 Hematology Research Center, Shiraz University of Medical Science, Shiraz, Iran
3 Department of Neurosurgery, Shiraz University of Medical Science, Shiraz, Iran
4 Trauma Research Center; Department of Pathology, Molecular Pathology and Cytogenetics Division, Shiraz University of Medical Science, Shiraz, Iran
Correspondence Address:
Majidreza Farrokhi
Department of Neurosurgery, Chamran Hospital, Shiraz
Iran
Sanaz Taherpour
Department of Neurosurgery, Chamran Hospital, Shiraz
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jcvjs.jcvjs_45_22
|
|
|
Giant cell tumor (GCT) is an intermediate malignant bone tumor which mostly involves long extremity bones, less commonly involving the spine with sacral predominance. Cervical spine involvement is rare. According to literature, the selective approach for the treatment of GCT is en bloc resection with spinal reconstruction. For unusual sites, such as cervical region, which is a mobile spinal segment and critically proximate to the cervical spinal cord, great vessels, and vital organs, it is almost impossible to perform the selective approach for treatment. Alternative approaches in such situations are under investigations. We present a case of C2 vertebral body GCT, who was treated with polymethylmethacrylate intravertebral injection and was followed by adjuvant therapy with denosumab. A 16-year-old boy without any past medical history presented with progressive suboccipital and axial neck pain since 3 months earlier, which had not responded to conservative treatments. There was no neurologic deficit, and pain was significantly controlled. In the 1-year follow-up, no complication and tumor recurrence was seen. Vertebroplasty with bone cement for lytic spinal GCT lesions, followed by adjuvant therapy with denosumab, not only is a less invasive treatment but also has good results in spinal stability, patient recovery, and 12-month recurrence.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
